Preprints.org

Real-World EHR Signals from a Cohort of Blinded Incretin Trial Participants Motivate Novel Indication Opportunities

At a glance

Exploratory kidney and blood-pressure signals warrant follow-up after unblinding.

The research question

Can routine-care biomarkers generate hypotheses while incretin trial assignments remain blinded?

Overview

The study explored organ-specific biomarker patterns across metabolic therapies.

Study design & methods

Twenty-five masked CagriSema/placebo participants were matched to 125 tirzepatide and 125 empagliflozin users; separate pramlintide comparisons provided pharmacologic context.

Principal findings

At six months, eGFR rose 26.4% in the masked cohort versus 6.5% with tirzepatide. Weight changes were not significantly different.

Limitations & interpretation

Preprint; not peer reviewed. The small, mixed active-treatment/placebo cohort cannot establish CagriSema efficacy or attribute signals to amylin. Residual confounding and routine-care measurement limit interpretation.

Publication type and venue follow the original nference listing. Read the original paper for full methods, analyses, and interpretation. View source listing.

Keep exploring.

All publications
CardiometabolismPreprint - Submitted for Peer-Review

Excessive Weight Loss with Zepbound Is Associated with Higher Rates of Adverse Events, Electrolyte Imbalances, and Hospitalization than Moderate Weight Loss

While residual confounding and documentation differences may contribute to some real-world associations, the significantly greater burden of adverse events, hospitalization rates, laboratory test anomalies, and vital-sign abnormalities among Zepbound patients with excessive weight loss warrants further investigation.

Preprints.org
October 21, 2026
CardiometabolismConference

Menopause Hormone Therapy and Weight Loss Response to GLP-1–Based Therapies in Midlife Women: A Retrospective Cohort Study

In this large real-world cohort of midlife women treated for overweight or obesity, concomitant HT was associated with significantly greater and sustained weight loss with SEM. A similar directional effect with TZP was observed at early timepoints but did not reach statistical significance. Larger prospective studies are warranted to confirm these observations and to inform individualized treatment strategies in midlife women.

The Menopause Society — 2026 Annual Meeting
October 20, 2026
Your next question could change everything.

What will you
discover next?

Let’s find out
Ideas are connected. Your next discovery starts here.